Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis. 2020;71(4):e1–e36.

Article  PubMed  PubMed Central  Google Scholar 

Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.

Article  CAS  PubMed  Google Scholar 

Kim J-Y, Kwak N, Yim J-J. The rise in prevalence and related costs of nontuberculous mycobacterial diseases in South Korea, 2010–2021. Open Forum Infect Diss: 2022. Oxford University Press US; 2022. p. ofac649.

Loebinger MR, Quint JK, van der Laan R, Obradovic M, Chawla R, Kishore A, van Ingen J. Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis. Chest 2023.

Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK. Increased risk of mycobacterial infections associated with anti-rheumatic medications. Thorax. 2015;70(7):677–82.

Article  PubMed  Google Scholar 

Chao W-C, Lin C-H, Liao T-L, Chen Y-M, Hsu C-Y, Chen J-P, Chen D-Y, Chen H-H. The risk of nontuberculous mycobacterial infection in patients with Sjögren’s syndrome: a nationwide, population-based cohort study. BMC Infect Dis. 2017;17(1):1–8.

Article  Google Scholar 

Kim H, Sung YK. Epidemiology of rheumatoid arthritis in Korea. J Rheum Dis. 2021;28(2):60–7.

Article  PubMed  PubMed Central  Google Scholar 

Winthrop KL, Iseman M. Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy. Nat Rev Rheumatol. 2013;9(9):524–31.

Article  PubMed  Google Scholar 

Yeh J-J, Wang Y-C, Sung F-C, Kao C-H. Rheumatoid arthritis increases the risk of nontuberculosis mycobacterial disease and active pulmonary tuberculosis. PLoS ONE. 2014;9(10):e110922.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario. Can Chest. 2014;146(3):563–72.

Article  PubMed  Google Scholar 

Yamakawa H, Takayanagi N, Miyahara Y, Ishiguro T, Kanauchi T, Hoshi T, Yanagisawa T, Sugita Y. Prognostic factors and radiographic outcomes of nontuberculous mycobacterial lung disease in rheumatoid arthritis. J Rheumatol. 2013;40(8):1307–15.

Article  PubMed  Google Scholar 

Takei H, Nishina N, Namkoong H, Suzuki K, Uwamino Y, Hasegawa N, Takeuchi T. Rheumatoid arthritis with nontuberculous mycobacterial pulmonary disease: a retrospective, single-centre cohort study. Mod Rheumatol. 2022;32(3):534–40.

Article  PubMed  Google Scholar 

Mori S, Koga Y, Nakamura K, Hirooka S, Matsuoka T, Uramoto H, Sakamoto O, Ueki Y. Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: a retrospective cohort study. PLoS ONE. 2020;15(12):e0243110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.

Article  PubMed  Google Scholar 

Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.

Article  CAS  PubMed  Google Scholar 

Kwak N, Hwang HW, Kim H-J, Lee HW, Yim J-J, Lee C-H. The Association between Bacille Calmette-Guérin Vaccination and Nontuberculous Mycobacterial Pulmonary Disease. J Korean Med Sci. 2022;37(26):e206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Ingen J, Aksamit T, Andrejak C, Böttger EC, Cambau E, Daley CL, Griffith DE, Guglielmetti L, Holland SM, Huitt GA. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J. 2018;51(3):1800170.

Article  PubMed  PubMed Central  Google Scholar 

Kim H-J, Kwak N, Hong H, Kang N, Im Y, Jhun BW, Yim J-J. BACES score for predicting mortality in nontuberculous mycobacterial pulmonary disease. Am J Respir Crit Care Med. 2021;203(2):230–6.

Article  CAS  PubMed  Google Scholar 

Kwak N, Kim SA, Choi SM, Lee J, Lee C-H, Yim J-J. Longitudinal changes in health-related quality of life according to clinical course among patients with non-tuberculous mycobacterial pulmonary disease: a prospective cohort study. BMC Pulm Med. 2020;20(1):1–7.

Article  Google Scholar 

Kwak N, Whang J, Yang JS, Kim TS, Kim SA, Yim J-J. Minimal inhibitory concentration of clofazimine among clinical isolates of nontuberculous mycobacteria and its impact on treatment outcome. Chest. 2021;159(2):517–23.

Article  CAS  PubMed  Google Scholar 

Jung HI, Kim SA, Kim H-J, Yim J-J, Kwak N. Anxiety and depression in patients with nontuberculous mycobacterial pulmonary disease: a prospective cohort study in South Korea. Chest. 2022;161(4):918–26.

Article  PubMed  Google Scholar 

Rosenbaum PR. Optimal matching for observational studies. J Am Stat Assoc. 1989;84(408):1024–32.

Article  Google Scholar 

Cobo-Ibáñez T, Descalzo MÁ, Loza-Santamaría E, Carmona L, Muñoz-Fernández S. Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0. Rheumatol int. 2014;34:953–61.

Article  PubMed  Google Scholar 

Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Nontuberculous mycobacteria infections and anti–tumor necrosis factor-α therapy. Emerg Infect Dis. 2009;15(10):1556.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Winthrop KL, Yamashita S, Beekmann S, Polgreen P, Network IDSAEI. Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clin Infect Dis. 2008;46(11):1738–40.

Article  PubMed  Google Scholar 

Park DW, Kim YJ, Sung Y-K, Chung SJ, Yeo Y, Park TS, Lee H, Moon J-Y, Kim S-H, Kim T-H. TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area. Sci Rep. 2022;12(1):4003.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Jhun BW, Moon SM, Jeon K, Kwon OJ, Yoo H, Carriere KC, Huh HJ, Lee NY, Shin SJ, Daley CL. Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study. Eur Respir J 2020, 55(1).

Kim J-Y, Kim NY, Jung H-W, Yim J-J, Kwak N. Old age is associated with worse treatment outcome and frequent adverse drug reaction in Mycobacterium avium complex pulmonary disease. BMC Pulm Med. 2022;22(1):1–9.

Article  Google Scholar 

Moon SM, Jhun BW, Baek S-Y, Kim S, Jeon K, Ko R-E, Shin SH, Lee H, Kwon OJ, Huh HJ. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease. Respir Med. 2019;151:1–7.

Article  PubMed  Google Scholar 

Kim J-Y, Choi Y, Park J, Goo JM, Kim TS, Seong M-W, Kwak N, Yim J-J. Impact of treatment on long-term survival of patients with Mycobacterium avium complex pulmonary disease. Clin Infect Dis 2023:ciad108.

Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatol. 2013;52(1):53–61.

Article  CAS  Google Scholar 

Shu C-C, Wu M-F, Pan S-W, Wu T-S, Lai H-C, Lin M-C. Host immune response against environmental nontuberculous mycobacteria and the risk populations of nontuberculous mycobacterial lung disease. J Formos Med Assoc. 2020;119:13–S22.

Article  Google Scholar 

Andréjak C, Nielsen R, Thomsen VØ, Duhaut P, Sørensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68(3):256–62.

Article  PubMed  Google Scholar 

Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand-Austin A, Gershon AS, Jamieson FB, Marras TK. The risk of mycobacterial infections associated with inhaled corticosteroid use. Eur Respir J 2017, 50(3).

Hwang JA, Kim S, Jo K-W, Shim TS. Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course. Eur Respir J 2017, 49(3).